Historique
Article de Périodique
Medical marijuana. What can we learn from the experiences in Canada, Germany and Thailand? (2019)
Auteur(s) :
REHM, J. ;
ELTON-MARSHALL, T. ;
SORNPAISARN, B. ;
MANTHEY, J.
Année :
2019
Page(s) :
47-51
Langue(s) :
Anglais
Domaine :
Drogues illicites / Illicit drugs
Discipline :
SAN (Santé publique / Public health)
Thésaurus géographique
CANADA
;
ALLEMAGNE
;
THAILANDE
Thésaurus mots-clés
CANNABIS
;
USAGE THERAPEUTIQUE
;
AUTOMEDICATION
;
ETUDE DE CAS
;
REGULATION
;
PROGRAMME
Résumé :
Cannabis policies are changing globally, and medical marijuana programs are part of these changes. Drawing from the examples of two high-income (Canada, an early adopter of medical marijuana, and Germany, a late adopter) and one middle-income (Thailand) countries, we illustrate two main pressures underlying these recent changes. First, in many high-income countries, cannabis has been used to self-medicate for different ailments and diseases, even though there is no evidence of effectiveness for many of these conditions. Second, the cannabis industry is pressuring governments and decision-makers to allow for medical marijuana use with lenient regulations - without specifying medical conditions (indications) and requiring only a prescription from a health professional to obtain it. As a result, demand is likely to increase, even in countries with low prevalence of use. Cannabis policy-makers need to consider a balance between the medical benefits of medical marijuana and the potential public health consequences and cost.
Affiliation :
Institute for Mental Health Policy Research, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada
Cote :
Abonnement